pharma news, views and analysis

in News
EMA clears compassionate use of Gilead’s remdesivir for COVID-19
April 7, 2020 Share
X
EMA clears compassionate use of Gilead’s remdesivir for COVID-19
https://pharmaphorum.com/news/ema-clears-compassionate-use-of-gileads-remdesivir-for-covid-19/
in News
AZ, GSK and Cambridge Uni will set up COVID-19 testing centre
April 7, 2020 Share
X
AZ, GSK and Cambridge Uni will set up COVID-19 testing centre
https://pharmaphorum.com/news/az-gsk-and-cambridge-uni-will-set-up-covid-19-testing-centre/

Latest News

FDA says all ranitidine drugs should be recalled on safety concerns

The FDA has asked drugmakers to pull all prescription and over-the-counter products based on ranitidine off the market

FDA says all ranitidine drugs should be recalled on safety concerns

https://pharmaphorum.com/news/fda-says-all-ranitidine-drugs-should-be-recalled-on-safety-concerns/

Jefferies heads $1 billion fundraiser for COVID-19 packaging drive

As research efforts to find drugs effective against COVID-19 gather pace, a public-private partnership has been set up

Jefferies heads $1 billion fundraiser for COVID-19 packaging drive

https://pharmaphorum.com/news/jefferies-heads-1-billion-fundraiser-for-covid-19-packaging-drive/

Pharma steps up as coronavirus cases soar to 400,000-plus

With the coronavirus pandemic gathering momentum outside China, AstraZeneca has said it will donate 9 million face masks

Pharma steps up as coronavirus cases soar to 400,000-plus

https://pharmaphorum.com/news/pharma-steps-up-as-coronavirus-cases-soar-to-400000-plus/

See all

Views & analysis

How behavioural science is helping in the fight against COVID-19

Thanks to COVID-19, just about every form of media we consume right now is focused on aspects of

How behavioural science is helping in the fight against COVID-19

https://pharmaphorum.com/views-analysis-patients/how-behavioural-science-is-helping-in-the-fight-against-covid-19/

Working with, advocating for, and empowering patients – a holistic view

In recent years, there has been a clear shift in pharma when it comes to how it interacts

Working with, advocating for, and empowering patients – a holistic view

https://pharmaphorum.com/views-analysis-patients/working-advocating-empowering-patient-centricity/

COVID-19 and cystic fibrosis – living on high alert in extraordinary times

As the global COVID-19 outbreak continues to tighten its grip, people with underlying respiratory conditions such as cystic

COVID-19 and cystic fibrosis – living on high alert in extraordinary times

https://pharmaphorum.com/views-analysis-patients/covid-19-and-cystic-fibrosis-living-on-high-alert-in-extraordinary-times/

See all

Debates & Insights

Understanding blockchain – a practical guide for life sciences companies

Within the life science industry, uptake of blockchain is in the early stages, but with investment levels in

Understanding blockchain – a practical guide for life sciences companies

https://pharmaphorum.com/digital/insights-digital/understanding-blockchain-life-sciences/

How pharma can boost engagement by embracing support networks

Connecting with patients has become a central plank in the pharma marketing playbook, but should companies be looking

How pharma can boost engagement by embracing support networks

https://pharmaphorum.com/patients/insights-patients/how-pharma-can-boost-engagement-by-embracing-support-networks/

Can simulated datasets unlock the potential of patient data?

Overview Patient level data offers the promise of insights which can craft new and better pathways, enable development

Can simulated datasets unlock the potential of patient data?

https://pharmaphorum.com/debates-insight-patients/can-simulated-datasets-unlock-the-potential-of-patient-data/

See all

Partner Content

Real-World Evidence 2020: Rare Diseases and Innovative Therapies

Explore practical applications of RWE in rare diseases

Real-World Evidence 2020: Rare Diseases and Innovative Therapies

https://pharmaphorum.com/events/real-world-evidence-2020-rare-diseases-and-innovative-therapies/

PatchAi startup now in the market to support patients and clinical research

Healthware Ventures invested in PatchAi

PatchAi startup now in the market to support patients and clinical research

https://pharmaphorum.com/partner-content/patchai-startup-now-in-the-market-to-support-patients-and-clinical-research/

Invitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019

SMi reports: Invitation from conference co-chair released for the 9th Annual Orphan Drugs & Rare Diseases conference, taking

Invitation to SMI’s Orphan Drugs & Rare Diseases Conference 2019

https://pharmaphorum.com/partner-content/invitation-to-smis-orphan-drugs-rare-diseases-conference-2019/

See all

Search

Advanced Search

Trending